As the senior director of the All of Us Research Program, Julia discusses how her experience has fueled innovative research to improve symptom management and health equity for patients with the condition
Mutation in the glucose 6 phosphate deshydrogenase gene leads to inactivation of Ku DNA end binding during oxidative Stress
Efficacy of GLP-1 RAs in Weight Loss GLP-1 RAs have consistently demonstrated effectiveness for weight loss in clinical trials among individuals with obesity compared with placebo treatments 17,18
Administering Epitalon in the evening or at bedtime is suggested to align with and potentially enhance the body's natural melatonin rhythms, which it helps to regulate, thereby supporting improved sleep and circadian function
Published in JAMA Network Open in 2024, the research dives into whether bariatric surgery or GLP-1 receptor agonist drugs offer a better shot at extending life for those battling both conditions
Lixisenatide, a drug developed to treat type 2 diabetes, shows neuroprotective effects in a mouse model of alzheimers disease